Currrax Pharmaceuticals over-performed its 2024 revenue goal and has exceeded 50% year-over-year revenue growth for its ...
West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...
According to Statifacts, the global clinical trials market size is calculated at USD 126.30 billion in 2025 and is expected to reach around USD 186.09 billion by 2034, growing at a CAGR of 4.4% from ...
Valuation discrepancies in the biotech sector highlight Shuttle Pharma’s incredible potential. With several peer companies in ...
Trump's tariff threats prompt Mexico and Canada to bolster anti-fentanyl efforts, while China's role remains contentious.
Bioanalytical Testing Services Market size is expected to reach USD 9.0 billion by 2033, achieving a compound annual growth rate (CAGR) of 9.8%.
Most of these innovations have been done by smaller companies, and R&D efforts by the biggest pharmaceutical companies have often been not very successful. Nevertheless, the pharmaceutical industry is ...
A slew of American companies have scaled back their diversity, equity and inclusion (DEI) initiatives over the past year amid pressure from activists and concerns over legal risks, but many are ...
Some are tracking attendance and firing employees who don't comply. Here's a list, in alphabetical order, of major companies requiring employees to return to offices. Business Insider will update ...
Swiss pharmaceutical giant Novartis on Friday ... 22% to $19.5 billion versus the $17.02 billion forecasted. The company said the sales growth was driven primarily by its blockbuster heart-failure ...
Are pharmaceutical companies earning too much? Deciding whether pharmaceutical companies earn too much money is complicated. In this issue of JAMA, 2 reports take different approaches to the question.
Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...